Neil Littman

Neil Littman is the Chief Executive Officer (CEO) of ReIGNITE Therapeutics, Inc., a company focused on developing high-capacity viral vector technologies.1 He is an experienced executive in the biotechnology and healthcare investment sectors with a diverse background spanning multiple roles and companies.

Career Highlights

Bioverge Ventures:: Littman is the Founder and General Partner of Bioverge Ventures, a financial technology platform he established in 2016. The company aims to make healthcare venture capital more accessible to various investors, providing opportunities to invest in cutting-edge healthcare startups.1

Notable:: Prior to his current role, Littman served as the Vice President of Business Development at Notable from August 2018 to February 2020. Notable is a translational drug development platform focused on blood cancer therapeutics.1

California Institute for Regenerative Medicine (CIRM):: From November 2012 to July 2018, Littman held the position of Director of Business Development at CIRM, where he was involved in strategic collaborations and partnerships with biopharma companies and investors.1

Educational Background

Littman attended the University of Colorado, Boulder, where he earned his Bachelor's degree in Molecular, Cellular, and Developmental Biology. During his time there, he also gained experience working in a virology lab.2

Professional Philosophy

Littman's professional focus appears to be on bringing innovative healthcare technologies to life. He has expressed a commitment to developing groundbreaking therapies and making investments in healthcare startups that are "pushing the boundaries of healthcare to bring science fiction to life".13